Tech and Bio: Data from a month of Verily and Caris Life Sciences Job Posts
PharmaPayWatch tracks US job postings at major pharma and biotech companies. Most of the companies we track are larger, ’traditional’ pharma companies, but in December 2024 we started tracking jobs from Caris Life Sciences and Verily Life Sciences.
Caris and Verily are more tech and data focused. Verily describe themselves as innovating at the “intersection of health and tech”1 and Caris’s diagnostics rely on big molecular data sets and developing AI capabilities. During our first month 2 of watching these companies we noticed a few patterns.
By The Numbers ¶
Between December 2024 and January 26 2025, Caris posted 60 positions, 22% of which were remote friendly, while Verily posted 45 positions, none of which are remote friendly. This is somewhat surprising, as we’ll note below, Verily is a very techincal company, with rules should be more conducive to remote work.
Overall, hiring patterns have been similar between the two companies, with a slight dip during the holidays and a recent increase in jobs posted.
Role Distribution ¶
Verily maintains a strong software focus with 64% of their roles being software/IT focused, compared to only 10% for Caris. Caris, on the other hand, is hiring heavily for both commercialization/business focused roles and scientific research.
Methods ¶
We collect data directly from company job pages. Data is collected roughly every 3-6 hours and updated on our website. We have been collecting jobs since November 2024, and have nearly 3,000 unique job postings across 13 companies as of January 26, 2025. We display active jobs on our job board and analyze the data looking for patterns or opportunities across the industry.
Next Steps ¶
This analysis covers only six weeks of data. We’ve set up a Verily vs Caris comparison page so you can stay up to date with trends and differences between the companies.
Data discussed here spans Dec 16, 2023 - Jan 26, 2024 ↩︎